Hjem › Atrieflimmer › Tennessee
Atrieflimmer kliniske forsøg i Tennessee
12 studier for Atrieflimmer søger deltagere på steder i Tennessee.
Byer i Tennessee
Officiel studietekst (engelsk)
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Tennessee Center for Clinical Trials, Tullahoma
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- East Coast Institute for Research, Jefferson City, Jefferson City
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07175428Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- Jackson-Madison County General Hospital, Jackson
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT04088071The Fourth Left Atrial Appendage Occlusion Study
- The University of Tennessee, Memphis
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT05963698Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Tennessee Center for Clinical Trials, Tullahoma
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07430956Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
- Erlanger Medical Center, Chattanooga
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT05723926Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- Vanderbilt University Medical Center, Nashville
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT07298473Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigational site 9954, Chattanooga
- Anthos Investigative Site 9941, Jefferson City
- Anthos Investigative Site 1056, Memphis
RekruttererFase 3
Alder 65 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT05712200BoxX-NoAF Clinical Trial
- Ascension Saint Thomas, Nashville
RekruttererFrivillige med god helbredstilstand velkomne
Alder 65 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT06989775Tracking Results of Ablations to Combat AF Registry Generation 2
- Jackson Madison County General Hospital, Jackson
- Centennial Medical Center, Nashville
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT05111015Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Fort Sanders Regional Medical Center, Knoxville
- Methodist University Hospital, Memphis
- Semmes Murphey Main Campus, Memphis
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. maj 2026 · NCT03907046Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
- Vanderbilt University Medical Center, Nashville
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT06575881Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.